EichorEICHOR
Study identifier: NCT07704840 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Recruiting

A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)

Condition: Post-Stroke Spasticity  ·  Sponsor: Alberto Esquenazi

PhasePhase 2
Planned participants42
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if the drug BMS-986368 works to treat post stroke spasticity in adults who have had a stroke. BMS-986368 is a designed to increase natural compounds in the body that may help calm nerves that cause muscles to be tight or spasm. The study will also learn about the safety of drug BMS-986368

This description comes directly from the study's public registry record.

Talk to the study team

Kareema Murray  ·  215-663-6290  ·  kareema.murray@jefferson.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Jeffersi=on Moss Magee RehabilitationElkins Park, Pennsylvania, United StatesRecruiting

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →